Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Genotypic and phenotypic evolution of HIV type-1 protease during in vitro sequential or concomitant combination of atazanavir and amprenavir.
ADS-J1 inhibits HIV-1 entry by interacting with gp120 and does not block fusion-active gp41 core formation.
Treatment simplification to once daily darunavir/ritonavir guided by the darunavir inhibitory quotient in heavily pretreated HIV-infected patients.
Could CD4 capture by CD8+ T cells play a role in HIV spreading?
Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications.
Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure.
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.
Effect of nevirapine on the steady-state trough concentrations of atazanavir in HIV-infected patients receiving atazanavir/ritonavir.
Clinical management of HIV-1 resistance.
Human papillomavirus HPV-16, 18, 52 and 58 integration in cervical cells of HIV-1-infected women.